azaspirene

structure in first source

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

1.	Aizawa, Mamoru: 1 article (05/2015)
2.	Choijamts, Batsuren: 1 article (05/2015)
3.	Emoto, Makoto: 1 article (05/2015)
4.	Hirasawa, Shun: 1 article (05/2015)
5.	Kanomata, Nobuhiro: 1 article (05/2015)
6.	Nabeshima, Kazuki: 1 article (05/2015)
7.	Sakai, Shinnosuke: 1 article (05/2015)
8.	Tachibana, Katsuro: 1 article (05/2015)
9.	Wakamori, Shinnosuke: 1 article (05/2015)
10.	Yano, Kyoko: 1 article (05/2015)

1.	Carcinosarcoma 05/01/2015 - "These azaspirene analogs may be effective against uterine carcinosarcoma, possibly acting via potent anti-angiogenic effects. " 05/01/2015 - "In the present study, the anti-angiogenic effects of azaspirene analogs, synthetic molecules with a shorter ethyl group replacing a hexadienyl side-chain of the natural compound, were assessed in vitro using human umbilical vein endothelial cells (HUVECs) co-cultured with FU-MMT-3 human uterine carcinosarcoma cells. " 05/01/2015 - "Azaspirene analogs inhibit the growth of human uterine carcinosarcoma in vitro and in vivo."
2.	Neoplasms (Cancer) 05/01/2015 - "The azaspirene analogs inhibited the tube formation of HUVECs induced by FU-MMT-3 cells in vitro and significantly suppressed tumor growth in vivo compared to the untreated group (control). " 09/01/2008 - "Azaspirene treatment reduced the number of tumor-induced blood vessels. "